Skip to main content
. 2017 Mar 29;26(143):160107. doi: 10.1183/16000617.0107-2016

FIGURE 1.

FIGURE 1

Percentage of baseline pulmonary vascular resistance (PVR) at week 16 in patients receiving bosentan or placebo in the BENEFIT study [39]. Reproduced and modified from [39] with permission.